Foresite Capital Management II’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-75,000
Closed -$7.52M 26
2015
Q1
$7.52M Sell
75,000
-96,824
-56% -$6.45M 4.46% 4
2014
Q4
$9.02M Buy
+171,824
New +$5.05M 6.17% 4

Foresite Capital Management II's ASPX Position: Q2 2015 in Review

Foresite Capital Management II sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 75,000 shares — an estimated $7.52M sold.

Foresite Capital Management II first reported a position in ASPX in Q4 2014 and held it in 2 quarters. The position peaked at $9.02M in Q4 2014. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

  • Foresite Capital Management II reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Foresite Capital Management II sold 75,000 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $7.52M.
  • Foresite Capital Management II first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q4 2014 and held it in 2 quarters.
  • Foresite Capital Management II's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $9.02M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on Foresite Capital Management II's 13F filing for Q2 2015, filed 14 Aug 2015.